Kyntra Bio(CH:KYNB)
CH:KYNB
Kyntra Bio earnings date
Kyntra Bio (KYNB) Q3 2026 Earnings Report
0 Followers
CH:KYNB Q3 2026 EPS Results
- Actual EPS
- CHF 0.03
- Consensus EPS
- -CHF 2.98
- Beat/Miss
- Beat by +CHF 3.01
- One Year Ago EPS
- CHF 41.63
CH:KYNB Q3 2026 Revenue Results
- Actual Revenue
- CHF 1.48M
- Expected Revenue
- CHF 1.48M
- Beat/Miss
- Missed by -CHF 5,034.811
- YoY Revenue Growth
- +63.57%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/16/2026
- Time
- After Close
- Conference Call
- Monday, November 16, 2026
CH:KYNB Upcoming Earnings
Kyntra Bio's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:KYNB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -2.95 | ― | ― |
| Nov 16, 2026 | 2026 (Q3) | ―0.03 | 41.63 | -99.92% (-41.60) | |
| Aug 13, 2026 | 2026 (Q2) | -2.672.48 | -1.58 | 257.45% (+4.06) | |
| May 11, 2026 | 2026 (Q1) | -2.82-3.16 | 1.05 | -400.80% (-4.20) | |
| Mar 16, 2026 | 2025 (Q4) | -3.26-2.95 | 3.78 | -178.00% (-6.72) | |
| Nov 10, 2025 | 2025 (Q3) | -3.3641.63 | -3.57 | 1267.29% (+45.20) | |
| Aug 11, 2025 | 2025 (Q2) | -1.93-1.58 | -3.36 | 53.00% (+1.78) | |
| May 12, 2025 | 2025 (Q1) | 0.631.05 | -6.92 | 115.15% (+7.97) | |
| Mar 17, 2025 | 2024 (Q4) | -2.943.78 | -11.96 | 131.58% (+15.73) | |
| Nov 12, 2024 | 2024 (Q3) | -6.43-3.57 | -13.64 | 73.85% (+10.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

